Serial Number
97796240
Owner
ALLIANCE PHARMA INC.Attorney
Christopher D. Olszyk, Jr.First Use Date
May 17, 2023
Filing Date
Feb 15, 2023
RESOLIAN ANALYTICAL SCIENCES Trademark
Serial Number: 97796240 • Registration: 7410179
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
February 15, 2023
Registration Date
June 4, 2024
First Use Anywhere
May 17, 2023
First Use in Commerce
May 17, 2023
Published for Opposition
January 9, 2024
Goods & Services
Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; Research and development in the fields of bioanalysis, immunoassay development, bioanalytical assay validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; Pharmaceutical research and development services; Chemical, bioanalytical, biological and biotechnology research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Pharmaceutical drug development services; Scientific testing in the fields of oncology, neurology, gastroenterology, immunology, endocrinology, gene therapy, infectious disease, rare and orphan diseases, cardiovascular disease, metabolic disease, central nervous system, ophthalmology, and respiratory diseases, for medical and pharmaceutical research purposes; Drug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; Scientific analytical laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development